We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$266M
AUM Growth
+$61.1M
Cap. Flow
+$48.5M
Cap. Flow %
18.26%
Top 10 Hldgs %
97.49%
Holding
26
New
2
Increased
7
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$31.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$20.7M
3
NTRA icon
Natera
NTRA
+$13.2M
4
TECH icon
Bio-Techne
TECH
+$12.9M
5
GH icon
Guardant Health
GH
+$6.09M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$22M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$10.1M
3
CELL
PhenomeX Inc. Common Stock
CELL
+$8.24M
4
A icon
Agilent Technologies
A
+$2.66M
5
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
+$18.6K

Sector Composition

Rank Sector Weight
1 Healthcare 83.88%
2 Materials 13.66%
3 Technology 1%
4 Financials 0.51%
5 Communication Services 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELL
26
DELISTED
PhenomeX Inc. Common Stock
CELL
– –
-163,977
Closed -$8.24M
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Blue Water Life Science Advisors held 26 positions worth $266M, up 30% from $205M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Blue Water Life Science Advisors deployed $48.5M of net new capital in Q2 2021, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was NeoGenomics: 702,222 shares worth $31.7M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 78% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was HTG Molecular Diagnostics, Inc. Common Stock, an estimated $18.6K trimmed.

  • Blue Water Life Science Advisors's largest Q2 2021 buy was NeoGenomics: 702,222 shares worth $31.7M.
  • Blue Water Life Science Advisors added most to Thermo Fisher Scientific in Q2 2021, an estimated $20.7M increase.
  • Blue Water Life Science Advisors's biggest Q2 2021 reduction was HTG Molecular Diagnostics, Inc. Common Stock, cutting an estimated $18.6K.
  • Blue Water Life Science Advisors fully exited Exact Sciences in Q2 2021, selling an estimated $22M.
  • Blue Water Life Science Advisors's ten largest holdings make up 97% of its $266M portfolio in Q2 2021.
  • Blue Water Life Science Advisors opened 2 new positions and closed 4 in Q2 2021.
  • Blue Water Life Science Advisors's portfolio value rose 30% quarter-over-quarter to $266M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.